Uncategorized

Q&A: Seaport CEO and CSO on learning from Karuna and the future of CNS research

Published

on

Seaport Therapeutics began trading as a public company on Friday after executives rang the Nasdaq’s opening bell.

With a team largely made up of Karuna Therapeutics veterans, Seaport is looking to push even further in …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version